Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Nurse practitioner care improves renal outcome in patients with CKD.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

J Am Soc Nephrol. 2014 Feb;25(2):390-8. doi: 10.1681/ASN.2012121222. Epub 2013 Oct 24.

2.

Increased fees, low wages.

Ligtenberg G.

Nurs N Z. 2012 May;18(4):3. No abstract available.

PMID:
22866452
3.

Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.

van Zuilen AD, Bots ML, Dulger A, van der Tweel I, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

Kidney Int. 2012 Sep;82(6):710-7. doi: 10.1038/ki.2012.137. Epub 2012 Jun 27.

4.

Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF.

Neth J Med. 2011 Nov-Dec;69(11):517-26.

5.

Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.

van Zuilen AD, Blankestijn PJ, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF.

Neth J Med. 2011 May;69(5):229-36.

6.

Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity.

Klein IH, Abrahams AC, van Ede T, Oey PL, Ligtenberg G, Blankestijn PJ.

J Hypertens. 2010 Sep;28(9):1928-34. doi: 10.1097/HJH.0b013e32833c20eb.

PMID:
20577127
7.

Quality of care in patients with chronic kidney disease is determined by hospital specific factors.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Bots ML, Wetzels JF; MASTERPLAN Study Group.

Nephrol Dial Transplant. 2010 Nov;25(11):3647-54. doi: 10.1093/ndt/gfq184. Epub 2010 Apr 9.

PMID:
20382963
8.

Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.

Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ.

J Hypertens. 2007 Jun;25(6):1285-9.

PMID:
17563543
9.

Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.

Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ.

Hypertension. 2007 Mar;49(3):506-10. Epub 2007 Jan 15.

PMID:
17224471
10.

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5.

11.

Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232].

van Zuilen AD, van der Tweel I, Blankestijn PJ, Bots ML, van Buren M, ten Dam MA, Kaasjager KA, van de Ven PJ, Vervoort G, Vleming LJ, Ligtenberg G, Wetzels JF; MASTERPLAN study group.

Trials. 2006 Mar 30;7:8.

12.

Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners.

Van Zuilen AD, Wetzels JF, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, Kaasjager KA, Van De Ven PJ, Vleming LJ, Ligtenberg G, Ligtenberg G; MASTERPLAN Study Group.

J Nephrol. 2005 Jan-Feb;18(1):30-4.

PMID:
15772920
13.

Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.

Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ.

J Am Soc Nephrol. 2004 Nov;15(11):2902-7.

14.

Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.

Blankestijn PJ, Ligtenberg G.

Semin Dial. 2004 Jul-Aug;17(4):265-9. Review.

PMID:
15250915
15.

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Moons P, Borm G, Hilbrands LB.

Am J Transplant. 2004 Jun;4(6):937-45.

16.

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.

Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ.

Kidney Int. 2004 May;65(5):1568-76. Review.

17.

Sympathetic nerve activity is inappropriately increased in chronic renal disease.

Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ.

J Am Soc Nephrol. 2003 Dec;14(12):3239-44.

18.

Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.

Grootscholten C, Ligtenberg G, Derksen RH, Schreurs KM, de Glas-Vos JW, Hagen EC, van den Wall Bake AW, Huizinga TW, van den Hoogen FH, Bijl M, van Houwelingen JC, Snoek FJ, Berden JH.

Qual Life Res. 2003 Sep;12(6):635-44.

PMID:
14516173
19.

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB.

J Am Soc Nephrol. 2003 Jul;14(7):1880-8.

20.

Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.

Grootscholten C, van Bruggen MC, van der Pijl JW, de Jong EM, Ligtenberg G, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Arthritis Rheum. 2003 May;48(5):1355-62.

21.

Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.

Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ.

J Am Soc Nephrol. 2003 Feb;14(2):425-30.

22.

Pathogenesis and treatment of hypertension in polycystic kidney disease.

Neumann J, Ligtenberg G, Klein IH, Blankestijn PJ.

Curr Opin Nephrol Hypertens. 2002 Sep;11(5):517-21. Review.

PMID:
12187316
23.

Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.

Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Hené RJ, Blom HJ, Demacker PN, Hilbrands LB.

Transplant Proc. 2002 Aug;34(5):1793-4. No abstract available.

PMID:
12176579
24.

Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.

Smak Gregoor PJ, de Sévaux RG, Ligtenberg G, Hoitsma AJ, Hené RJ, Weimar W, Hilbrands LB, van Gelder T.

J Am Soc Nephrol. 2002 May;13(5):1365-73.

25.

Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects.

Klein IH, Abrahams A, van Ede T, Hené RJ, Koomans HA, Ligtenberg G.

Transplantation. 2002 Mar 15;73(5):732-6.

PMID:
11907418
26.

Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.

Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ.

J Am Soc Nephrol. 2001 Nov;12(11):2427-33.

27.

Mechanisms and consequences of arterial hypertension after renal transplantation.

Koomans HA, Ligtenberg G.

Transplantation. 2001 Sep 27;72(6 Suppl):S9-12. Review.

PMID:
11585243
28.

Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus.

Ligtenberg G, Hené RJ, Blankestijn PJ, Koomans HA.

J Am Soc Nephrol. 2001 Feb;12(2):368-73.

29.

Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance.

Blankestijn PJ, Ligtenberg G, Klein IH, Koomans HA.

Nephrol Dial Transplant. 2000 Jun;15(6):755-8. Review. No abstract available.

PMID:
10831622
30.
31.

Preoperative evaluation of living renal donors with gadolinium-enhanced magnetic resonance angiography.

Bakker J, Ligtenberg G, Beek FJ, van Reedt Dortland RW, Hené RJ.

Transplantation. 1999 Apr 27;67(8):1167-72.

PMID:
10232569
32.

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.

Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA.

N Engl J Med. 1999 Apr 29;340(17):1321-8.

33.

Intradialytic hypotension: new insights into the mechanism of vasovagal syncope.

Ligtenberg G, Barnas MG, Koomans HA.

Nephrol Dial Transplant. 1998 Nov;13(11):2745-7. No abstract available.

PMID:
9829472
34.

Presyncope during progressive hypovolaemia simulated by lower body negative pressure is not prevented by high-dose naloxone.

Ligtenberg G, Blankestijn PJ, Koomans HA.

Nephrol Dial Transplant. 1998 Feb;13(2):398-403.

PMID:
9509453
35.

Hemodynamic response during lower body negative pressure: role of volume status.

Ligtenberg G, Blankestijn PJ, Koomans HA.

J Am Soc Nephrol. 1998 Jan;9(1):105-13.

36.

Cold stress provokes sympathoinhibitory presyncope in healthy subjects and hemodialysis patients with low cardiac output.

Ligtenberg G, Blankestijn PJ, Oey PL, Wieneke GH, van Huffelen AC, Koomans HA.

Circulation. 1997 May 6;95(9):2271-6.

PMID:
9142004
37.

[Treatment of nephritis in systemic lupus erythematodes].

Ligtenberg G, Derksen RH, Berden JH.

Ned Tijdschr Geneeskd. 1996 Sep 28;140(39):1941-4. Review. Dutch. No abstract available.

PMID:
8927179
38.

No change in automatic function tests during uncomplicated haemodialysis.

Ligtenberg G, Blankestijn PJ, Boomsma F, Koomans HA.

Nephrol Dial Transplant. 1996 Apr;11(4):651-6.

PMID:
8671853
39.

Erysipelas: not always innocent.

Ligtenberg G, Blankestijn PJ, Koomans HA.

Neth J Med. 1993 Oct;43(3-4):179-82.

PMID:
8302397
40.

Phaeochromocytoma in a long-term haemodialysis patient; diagnosis and management.

Ligtenberg G, Blankestijn PJ, Koomans HA.

Nephrol Dial Transplant. 1993;8(10):1172-3. No abstract available.

PMID:
8272234

Supplemental Content

Loading ...
Support Center